Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified FibrinogenArticle Published on 2024-02-162024-09-05 Journal: Biomolecules [Category] update2024, [키워드] FIBRIN fibrinogen thrombin thrombosis Tissue Factor [DOI] 10.3390/biom14020230 PMC 바로가기 [Article Type] Article
Chemical Adjustment of FibrinolysisOpinion Published on 2024-01-102024-09-05 Journal: Pharmaceuticals [Category] update2024, [키워드] FIBRIN Ischemic Stroke plasmin Thrombolysis tissue plasminogen activator [DOI] 10.3390/ph17010092 PMC 바로가기 [Article Type] Opinion
Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 conditionarticle Published on 2023-07-262024-09-05 Journal: The Cochrane database of systematic reviews [Category] update2024, [키워드] COVID-19 FIBRIN Fibrin/therapeutic use humans Plasmapheresis [DOI] 10.1002/14651858.CD015775 PMC 바로가기 [Article Type] article
The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1Article Published on 2022-10-012022-11-16 Journal: Journal of thrombosis and haemostasis : JTH [Category] 변종, [키워드] 113 patient analyzed attenuate clot cofactor Complication confocal microscopy correlated COVID-19 COVID-19 disease COVID-19 sample disease drugs dysregulation elevated ELISA faster fiber FIBRIN fibrinolysis fibrinolytic fibrinolytic system groups healthy control healthy controls highlight Hospitalized inhibitor Non-COVID-19 PAI-1 Patient patients with COVID-19 plasma profile prognostic Prospective Study quantified respiratory diseases respiratory infection reveal severe COVID-19 disease severity significantly substrates thrombotic complication tissue plasminogen activator treat variant Vitronectin with COVID-19 [DOI] 10.1111/jth.15806 PMC 바로가기
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placental Infection Is Associated With Massive Perivillous Fibrin Deposition at the Maternal-Fetal Interface: A Preliminary Study중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 태반 감염은 모체-태아 경계면에서 대규모 Perivillous 섬유소 침착과 관련이 있습니다: 예비 연구Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 치료기술, [키워드] 2 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alpha variant Chain Reaction coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 CoV COVID-19 deposition FIBRIN fibrin deposition Frequency immunohistochemistry massive pandemic Placenta polymerase chain polymerase chain reaction respiratory reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS SARS-CoV-2 sequenced severe acute respiratory syndrome Coronavirus [DOI] 10.1093/cid/ciac173 PMC 바로가기 [Article Type] Article
Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patientsCOVID-19 환자로부터 회수된 혈전에서 SARS-CoV-2 스파이크 단백질의 증거Article Published on 2022-08-162022-09-11 Journal: Journal of Hematology & Oncology [Category] SARS, 치료기술, 치료법, [키워드] activate addition analyzed Chain Reaction Coagulopathy complex COVID-19 COVID-19 patient detect evidence of FIBRIN Hypothesis Ischemic Stroke Molecular biology Myocardial infarction nucleocapsid protein ogen pathophysiology pilot study Platelet platelet activation Platelets polymerase chain polymerase chain reaction real-time polymerase chain reaction retrieved SARS-CoV-2 RNA SARS-CoV-2 spike protein Spike protein stroke Support These data thrombi Trigger virus [DOI] 10.1186/s13045-022-01329-w PMC 바로가기 [Article Type] Article
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)COVID-19의 긴 COVID/급성 후유증(PASC)을 가진 개인의 증상, 동반질환, 섬유소 아밀로이드 미세응고 및 혈소판 병리의 유병률Article Published on 2022-08-062022-09-11 Journal: Cardiovascular Diabetology [Category] SARS, 진단, 치료기술, [키워드] accompanied acute COVID-19 African amyloid Amyloid fibrin(ogen) analysed Atypical balance blood sample Blood samples Brain capillary cardiovascular disease cholesterol Clinical studies clinical study Clinical treatment co-morbidities Comorbidities Comorbidity comparable Concentration controlled clinical studies coronavirus coronavirus 2019 disease COVID-19 COVID-19 severity determine diabetes Diabetes Mellitus Diagnostic method Diversity dyslipidaemia Early detection effective Efficacy endotheliopathy fatigue female FIBRIN Fluorescence fluorescence microscopy foci Gender Hyperactivated platelets hypertension individual inhibit joint Long Long COVID/PASC morbidities muscle pains ogen PASC pathology Patient patients Platelet platelet hyperactivation Platelets platform provide reducing registry removal reported reversal SARS-COV-2 infection scoring system Shortness of breath South Symptom Symptoms tissues Transport Treatment type 2 diabete Type 2 diabetes mellitus [DOI] 10.1186/s12933-022-01579-5 PMC 바로가기 [Article Type] Article
Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection코로나19 감염으로 입원한 환자에서 관상동맥 미세혈관 기능장애가 흔하다Article Published on 2022-07-012022-09-11 Journal: Microcirculation (New York, N.Y. : 1994) [Category] MERS, 바이오마커, [키워드] Admission Biomarker Biomarkers C-reactive protein control subject Coronary coronary microvascular dysfunction correlated COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients D-dimer demonstrated dimer disease driven by driver dysfunction echocardiographic echocardiography Evidence explain FIBRIN flow velocity highest Hospitalized Infection Inflammation interleukin interleukin-6 Moderate COVID-19 morbidity morbidity and mortality Myocardial myocardial injury Patient patients hospitalized patients with COVID-19 peptide resulting SARS-CoV-2 severe COVID-19 Severe COVID-19 Infection severity significantly lower the patient tissue troponin was done with COVID-19 [DOI] 10.1111/micc.12757 PMC 바로가기 [Article Type] Article
Pulmonary lesions induced by SARS-CoV-2 infection in domestic cats집고양이에서 SARS-CoV-2 감염으로 유발된 폐 병변Article Published on 2022-07-012022-09-11 Journal: Veterinary pathology [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute infection acute respiratory syndrome acute respiratory syndrome coronavirus affected alveolar alveolar fibrin B and T lymphocytes Blood blood vessel bronchiolar Bronchiolitis cat cats Chain Reaction consolidation coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 disease DPI Endothelium epithelial expression fatal disease FIBRIN fibrosis histologic Histopathology hypertrophy immunohistochemistry in some individuals Infection interstitial pneumonia lesion limit of detection lung Lung disease lung lesion macrophages MHC II Microscopic Mild mild to moderate moderate occlusive patchy Patient Pneumonia polymerase chain polymerase chain reaction proliferation pulmonary pulmonary lesion pulmonary lesions quantitative polymerase chain reaction reactive respiratory signs reverse transcriptase SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA septal thickening severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 T lymphocytes type II pneumocytes vacuolar vacuolar degeneration Vasculitis vessel Viral load viral loads Viral RNA [DOI] 10.1177/03009858211066840 PMC 바로가기 [Article Type] Article
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies분무형 HepArin이 침습적 인공호흡이 필요한 COVID-19 환자의 사망률과 발관까지의 시간을 줄일 수 있습니까?Article Published on 2022-07-012022-09-11 Journal: British Journal of Clinical Pharmacology [Category] COVID19(2023년), SARS, 임상, [키워드] Activation alveolar fibrin Analysis Anti-inflammatory ARDS blinded Can clinical study clinical trial Coagulation controlled clinical trials country COVID-19 COVID-19 pneumonia dataset days alive defined Effect endpoints Evidence extubation FIBRIN FIVE heparin hypoxaemic respiratory failure Infection Inhaled International invasive ventilation investigator-initiated Laboratory limit lung Lung injury mammalian cells meta-trial Microvascular thrombosis nebulised heparin open label pandemic patient data patients with COVID-19 Placebo placebo-controlled Pneumonia Prevent Primary outcome progression randomised randomised controlled randomised study RCT receive Respiratory failure resulting SARS SARS-CoV-2 SARS-CoV-2 virus standard care Statistical analysis plan the SARS-CoV-2 virus therapy thrombosis unfractionated heparin ventilator-free day Ventilator-free days with COVID-19 [DOI] 10.1111/bcp.15253 PMC 바로가기 [Article Type] Article